Skip to main content

Hybrid UHPLC and HPLC Columns and Media: YMC-Triart Diol-HILIC

There is a lot of interest in HILIC (hydrophilic interaction liquid chromatography), particularly among LC/MS users.  Mobile phases used in HILIC separations are generally “LC/MS friendly.”

YMC-Triart Diol-HILIC begins with an organic/inorganic hybrid base particle with excellent durability and usability across a wide pH range.  It is then synthesized with a dihydroxypropyl (Diol) group.  The resulting material is ideal for the separation of polar compounds that are not retained well using other methods.

ymcamerica-triartc18hybrid-column-smallThe diol group is a neutral functional group that exhibits low nonspecific adsorption.  YMC-Triart Diol-HILIC displays excellent reproducibility.  These columns also exhibit increased stability under alkaline conditions as compared to silica based diol columns.  YMC-Triart Diol-HILIC is rated with a pH range of 2-10.  Available particle sizes are 1.9µm, 3µm, and 5µm.

For more information on YMC-Triart Diol-HILIC, please visit our website:

https://www.ymcamerica.com/columns/special/hilic.htm

Posted on January 26, 2016.

Related Posts

April 14, 2026

Novel Approach for Differentiating mRNA Fingerprints

𝗡𝗲𝘄 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗶𝗻 𝗺𝗡𝗥𝗔 𝗙𝗶𝗻𝗴𝗲𝗿𝗽𝗿𝗶𝗻𝘁𝗶𝗻𝗴: 𝗜𝗣𝗔𝗫 𝘅 𝗜𝗣-𝗥𝗣 𝟮𝗗-𝗟𝗖 Confirming mRNA sequences quickly and reliably is no longer a bottleneck. While traditional sequencing or LC-HRMS workflows are often labor-intensive, a 𝐭𝐰𝐨-𝐝𝐢𝐦𝐞𝐧𝐬𝐢𝐨𝐧𝐚𝐥 𝐥𝐢𝐪𝐮𝐢𝐝 𝐜𝐡𝐫𝐨𝐦𝐚𝐭𝐨𝐠𝐫𝐚𝐩𝐡𝐲 (𝟐𝐃-𝐋𝐂) approach is simplifying comprehensive mRNA characterization.

March 11, 2026

We are hiring!

We are growing and we're hiring across all functions! It takes a diverse and skilled team to do what we do, from the initial engineering concept, to the final high-polish finish, to the regional sales champions, and step in between that drives us forward.

September 9, 2025

We are Attending Boulder Peptide Symposium

Starting Monday: YMC Heads to the Boulder Peptide Symposium! September 15–18 | Boulder, CO We’re eager to attend this one-of-a-kind event, the only conference solely focused on the pharmaceutical development of peptide therapeutics. We are excited for the rapid-fire, 15-minute

Designed and developed by